Showing results (1881-1890 of 1,985) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.The Lancet. Neurology|March 25, 2022
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosisStephen A Goutman, Orla Hardiman, Ammar Al-Chalabi, et al.The Lancet. Neurology|June 5, 2019
Migraine and the trigeminovascular system-40 years and countingMessoud Ashina, Jakob Møller Hansen, Thien Phu Do, et al.The Lancet. Neurology|June 24, 2019
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyHeather Wilson, George Dervenoulas, Gennaro Pagano, et al.The Lancet. Neurology|June 28, 2017
Gadolinium deposition in the brain: summary of evidence and recommendationsVikas Gulani, Fernando Calamante, Frank G Shellock, et al.The Lancet. Neurology|March 2, 2010
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS)Leo H Bonati, Lisa M Jongen, Sven Haller, et al.The Lancet. Neurology|August 21, 2016
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trialLudwig Kappos, Douglas L Arnold, Amit Bar-Or, et al.The Lancet. Neurology|April 14, 2023
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 studyVera Bril, Artur Drużdż, Julian Grosskreutz, et al.The Lancet. Neurology|April 24, 2021
Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control studyHenk-Jan Westeneng, Kevin van Veenhuijzen, Rick A van der Spek, et al.The Lancet. Neurology|March 15, 2015
Axon guidance proteins in neurological disordersEljo Y Van Battum, Sara Brignani, R Jeroen PasterkampPageof 199